Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II

NCT02230241 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02230241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02230241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 30, 2014
Completion date
November 30, 2015
Enrollment
2,700 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidaemia